|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Research Article |
1 Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
2 InSight Ltd., Rehovot, Israel
3 Weizmann Institute of Science, Rehovot, Israel
4 Hadassah-Hebrew University Hospital, Jerusalem, Israel
* Author for correspondence (e-mail: sbkatz{at}netvision.net.il )
Accepted 12 December 2001
Heparanase is a heparan-sulfate-degrading endoglycosidase that has important roles in various biological processes, including angiogenesis, wound healing and metastatsis. Human heparanase is synthesized as a 65 kDa latent precursor, which is proteolytically processed into a highly active 50 kDa form. Extracellular heparanase is found in various tissues and is utilized by both normal cells and metastatic cancer cells to degrade heparan sulfate moieties in basement membranes and extracellular matrices. This study characterizes the processing and trafficking events associated with cellular activation of extracellular heparanase. We show that primary human fibroblasts are capable of binding and converting the 65 kDa heparanase precursor into its highly active 50 kDa form, concomitantly with its cytoplasmic accumulation. Heparanase uptake depends on the actin cytoskeleton integrity, resulting in a prolonged storage of the enzyme, mainly in endosomal structures. Heparanase endocytosis and its proteolytic activation are independent processes, indicating that heparanase cleavage is a cell surface event. Heparin completely inhibits heparanase endocytosis but only partially inhibits its association with the cells, suggesting that cell surface heparan sulfate moieties play a specific role in its endocytosis. Cellular binding and uptake of extracellular heparanase control its activation, clearance rate and storage within the cells.
Key words: Endocytosis, Heparan sulfate proteoglycans, Heparanase, Processing
This article has been cited by other articles:
|
|
 |
|
  G. E. Bertolesi, G. Michaiel, and S. McFarlane Two Heparanase Splicing Variants with Distinct Properties Are Necessary in Early Xenopus Development J. Biol. Chem., June 6, 2008; 283(23): 16004 - 16016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Wood and M. D. Hulett Cell Surface-expressed Cation-independent Mannose 6-Phosphate Receptor (CD222) Binds Enzymatically Active Heparanase Independently of Mannose 6-Phosphate to Promote Extracellular Matrix Degradation J. Biol. Chem., February 15, 2008; 283(7): 4165 - 4176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. N. Patel, S. M. Knox, K. M. Likar, C. A. Lathrop, R. Hossain, S. Eftekhari, J. M. Whitelock, M. Elkin, I. Vlodavsky, and M. P. Hoffman Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis Development, December 1, 2007; 134(23): 4177 - 4186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Shafat, I. Vlodavsky, and N. Ilan Characterization of Mechanisms Involved in Secretion of Active Heparanase J. Biol. Chem., August 18, 2006; 281(33): 23804 - 23811. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zetser, Y. Bashenko, E. Edovitsky, F. Levy-Adam, I. Vlodavsky, and N. Ilan Heparanase Induces Vascular Endothelial Growth Factor Expression: Correlation with p38 Phosphorylation Levels and Src Activation Cancer Res., February 1, 2006; 66(3): 1455 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. de Mestre, S. Rao, J. R. Hornby, T. Soe-Htwe, L. M. Khachigian, and M. D. Hulett Early Growth Response Gene 1 (EGR1) Regulates Heparanase Gene Transcription in Tumor Cells J. Biol. Chem., October 21, 2005; 280(42): 35136 - 35147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Vreys, N. Delande, Z. Zhang, C. Coomans, A. Roebroek, J. Durr, and G. David Cellular Uptake of Mammalian Heparanase Precursor Involves Low Density Lipoprotein Receptor-related Proteins, Mannose 6-Phosphate Receptors, and Heparan Sulfate Proteoglycans J. Biol. Chem., September 30, 2005; 280(39): 33141 - 33148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Sotnikov, R. Hershkoviz, V. Grabovsky, N. Ilan, L. Cahalon, I. Vlodavsky, R. Alon, and O. Lider Enzymatically Quiescent Heparanase Augments T Cell Interactions with VCAM-1 and Extracellular Matrix Components under Versatile Dynamic Contexts J. Immunol., May 1, 2004; 172(9): 5185 - 5193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sasaki, N. Higashi, T. Taka, M. Nakajima, and T. Irimura Cell Surface Localization of Heparanase on Macrophages Regulates Degradation of Extracellular Matrix Heparan Sulfate J. Immunol., March 15, 2004; 172(6): 3830 - 3835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Levidiotis, C. Freeman, C. Tikellis, M. E. Cooper, and D. A. Power Heparanase Is Involved in the Pathogenesis of Proteinuria as a Result of Glomerulonephritis J. Am. Soc. Nephrol., January 1, 2004; 15(1): 68 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. de Mestre, L. M. Khachigian, F. S. Santiago, M. A. Staykova, and M. D. Hulett Regulation of Inducible Heparanase Gene Transcription in Activated T Cells by Early Growth Response 1 J. Biol. Chem., December 12, 2003; 278(50): 50377 - 50385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zetser, Y. Bashenko, H.-Q. Miao, I. Vlodavsky, and N. Ilan Heparanase Affects Adhesive and Tumorigenic Potential of Human Glioma Cells Cancer Res., November 15, 2003; 63(22): 7733 - 7741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. GOLDSHMIDT, E. ZCHARIA, M. COHEN, H. AINGORN, I. COHEN, L. NADAV, B.-Z. KATZ, B. GEIGER, and I. VLODAVSKY Heparanase mediates cell adhesion independent of its enzymatic activity FASEB J, June 1, 2003; 17(9): 1015 - 1025. [Abstract] [Full Text] [PDF]
|
|
